Investigation of Neurokinin‐1 Receptor Antagonism as a Novel Treatment for Chronic Bronchitis in Dogs

BACKGROUND: Canine chronic bronchitis (CCB) results in cough lasting ≥2 months and airway inflammation. Adverse effects include risk of secondary infection associated with lifelong corticosteroid administration and prompt investigation into alternative therapies. Neurogenic pathways mediated by tach...

Descripción completa

Detalles Bibliográficos
Autores principales: Grobman, M., Reinero, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913560/
https://www.ncbi.nlm.nih.gov/pubmed/26995558
http://dx.doi.org/10.1111/jvim.13935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913560/
https://www.ncbi.nlm.nih.gov/pubmed/26995558
http://dx.doi.org/10.1111/jvim.13935

Ejemplares similares